(3α,5β,11β)-3,11,17,21-Tetrahydroxy-20-oxopregnan-18-al, is a derivative of Tetrahydrocortisol (T293370), that has been found to be produced by lymphocytes in both normal and cancer bearing patients however, the concentration of Tetrahydrocortisol has increased in patients with cancer.